Mechanism of the antiischemic effect of mibefradil, a selective T calcium channel blocker in dogs: Comparison with amlodipine

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 1, 1996, Pages 132-139

  Roux, Sébastien ^a   Bühler, Manfred ^a   Clozel, Jean Paul ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Amlodipine; Calcium channel blockers; Mibefradil; Myocardial ischemia; Variant angina

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; MIBEFRADIL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY SPASM; DOG; DRUG EFFECT; HEART HEMODYNAMICS; HEART MUSCLE ISCHEMIA; HEART RATE; NONHUMAN; PRIORITY JOURNAL;

AMLODIPINE; ANGINA PECTORIS, VARIANT; ANIMALS; BENZIMIDAZOLES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DOGS; HEART RATE; INTRA-AORTIC BALLOON PUMPING; MIBEFRADIL; MYOCARDIAL ISCHEMIA; TETRAHYDRONAPHTHALENES;

EID: 0030034184     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199601000-00021     Document Type: Article

References (40)

1. Waters DD, Théroux P, Szlachcic J, Dauwe F. Provocative testing with ergonovine to assess the efficacy of treatment with nifedipine. diltiazem and verapamil in variant angina. Am J Cardiol 1981;48:123-30.
2. Vatner SF, Hintze TH. Effects of a calcium-channel antagonist on large and small coronary arteries in conscious dogs. Circulation 1982;66:579-88.
3. Ganz W, Marcus HS. Failure of intracoronary nitroglycerin to alleviate pacing induced angina. Circulation 1972;46:880-9.
4. 2+ channels by Ro 40-5967. Circ Res 1994;75:144-8.
5. Clozel JP, Banken L, Osterrieder W. Effects of Ro 40-5967, a novel calcium antagonist, on myocardial function during ischemia induced by lowering coronary perfusion pressure in dogs: comparison with verapamil. J Cardiovasc Pharmacol 1989;14:713-21.
6. Ezzaher A, Bouanani N, Su JB, Hittinger L, Crozatier B. Increased negative inotropic effect of calcium-channel blockers in hypertrophied and failing rabbit heart. J Pharmacol Exp Ther 1991;257:466-71.
7. Su J, Renaud N, Carayon A, Crozatier B, Hittinger L. Effects of the calcium channel blockers, diltiazem and Ro 40-5967, on systemic haemodynamics and plasma noradrenaline levels in conscious dogs with pacing-induced heart failure. Br J Pharmacol 1994;113:395-402.
8. Vassort G, Alvarez J. Cardiac T-type calcium current: pharmacology and roles in cardiac tissues. J Cardiovasc Electrophysiol 1994;5:376-93.
9. Portegies MCM, Schmitt R, Kraaij CJ, et al. Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris. J Cardiovasc Pharmacol 1991;18:746-51.
10. Chahine RA, Feldman RL, Giles TD, et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol 1993;21:1365-70.
11. Lehmann G, Reiniger G, Beyerle A, Rudolph W. Pharmacokinetics and additional anti-ischaemic effectiveness of amlodipine, a once-daily calcium antagonist, during acute and long term therapy of stable angina pectoris in patients pretreated with a beta-blocker. Eur Heart J 1993;14:1531-5.
12. Gross GJ, Warltier DC. Selective improvement in subendocardial perfusion distal to a flow-limiting coronary artery stenosis: effects of the new calcium channel blocking agent, FR 34235, nifedipine and diltiazem. J Pharmacol Exp Ther 1984;228:531-6.
13. Théroux P, Franklin D, Ross J Jr, Kemper WS. Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog. Circ Res 1974;35:896-908.
14. Sarnoff SJ, Braunwald E, Welch GH, Case RB, Stainsby WN, Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol 1958;192:148-56.
15. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest 1975;56:978-85.
16. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation 1990;82:2044-51.
17. 1adrenergic mechanism. Circ Res 1993; 73:656-70.
18. Heymann MA, Payne BD, Huffman JIE, Rudolph AM. Blood flow measurements with radionuclitie-labeled particles. Prog Cardiovasc Dis 1977;20:55-79.
19. 2+ current is expressed in hypertrophied adult feline left ventricular myocytes. Circ Res 1993;73:777-82.
20. 2+ channels are abnormal in genetically determined cardiomyopathic hamster hearts. Circ Res 1994;75:149-55.
21. Zhou Z, Lipsius SL. T-type calcium current in latent pacemaker cells isolated from cat right atrium. J Mol Cell Cardiol 1994;26:1211-9.
22. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol 1988;395:233-53.
23. Indolfi C, Ross J Jr. The role of heart rate in myocardial ischemia and infarction: implications of myocardial perfusion-contraction matching. Prog Cardiovasc Dis 1993;36:61-74.
24. Olsson RA, Gregg DE. Myocardial reactive hyperemia in the unanesthetized dog. Am J Physiol 1965;208:224-30.
25. Vatner SF. Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res 1980;47:201-7.
26. Weintraub WS, Hattori S, Agarwal JB, Bodenheimer MM, Banka VS, Helfant RH. The relationship between myocardial blood flow and contraction by myocardial layer in the canine left ventricle during ischemia. Circ Res 1981;48:430-8.
27. Bourassa MG, Coté P, Théroux P, Tubau JF, Genain C, Waters DD. Hemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans. Chest 1980;78:224S-30S.
28. Jolly SR, Gross GJ. Improvement in ischemic myocardial blood flow following a new calcium antagonist. Am J Physiol 1980;239:H163-71.
29. Clozel JP, Théroux P, Bourassa MG. Effects of diltiazem on experimental myocardial ischemia and on left ventricular performance. Circ Res 1983;52(suppl l):I120-8.
30. Bache RJ, Dymek DJ. Effect of diltiazem on myocardial blood flow. Circulation 1982;65(suppl 1):I19-26.
31. Bache RJ, Tockman BA. Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow-limiting coronary stenosis in the awake dog. Circ Res 1982; 50:678-87.
32. Matsuzaki M, Gallagher KP, Patritti J, et al. Effects of a calcium-entry blocker (diltiazem) on regional myocardial blood flow and function during exercise in conscious dogs. Circulation 1984;69:801-14.
33. Grover GJ, Sleph PG, Parham CS, Brittain RJ, Krapcho J, Moreland S. Antiischemic activity of the novel benzazepine calcium antagonist SQ 31,486. J Cardiovasc Pharmacol 1990;16:219-27.
34. Grover GJ, Parham CS. The effect of diltiazem on ST-segment elevation and myocardial blood flow distribution during pacing-induced ischemia. Eur J Pharmacol 1987;143:109-17.
35. Pelc LR, Gross GJ, Warltier DC. Effects of KB-944, a novel calcium antagonist, in several models of canine myocardial ischemia. J Pharmacol Exp Ther 1986;238:113-8.
36. Perez JE, Sobel BE, Henry PD. Improved performance of ischemic canine myocardium in response to nifedipine and diltiazem. Am J Physiol 1980;239:H658-63.
37. Urquhart J, Patterson RE, Bacharach SL, et al. Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs. Circulation 1984;69:382-90.
38. Baumgart D, Ehring T, Heusch G. A proischaemic action of nisoldipine: relationship to a decrease in perfusion pressure and comparison to dipyridamole. Cardiovasc Res 1993;27:1254-9.
39. Fu WK, Yong AC, Gangell P, Roberts MS, Kilpatrick D. The effects of nifedipine on the systemic and coronary vascular beds of the sheep: a potential method for induction of ischaemia. Clin Exp Pharmacol Physiol 1985;12:407-15.
40. Thuillez C, Maury M, Giudicelli JF. Differential effects of verapamil and diltiazem on regional blood flow and function in the canine normal and ischemic myocardium. J Cardiovasc Pharmacol 1983;5:19-27.